3B Blackbio (3BBLACKBIO) | Stock Overview & Key Data
3B Blackbio Performance Comparison
Stock Range
Today's Range
Low: ₹1,407.05
High: ₹1,448.00
on August 26, 2025
52 Week Range
Low: ₹1,253.80
High: ₹2,350.00
on October 7, 2024
on December 11, 2024
All-Time High: ₹2,350.00 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR12.3B
EPS
57.31
P/E Ratio (TTM)
25.06
Forward P/E
N/A
P/B Ratio
4.79
PEG Ratio
1.91
Div. Yield
N/A
ROE
17.58%
Beta
0.275
Debt to Equity
0.11
Financial Highlights
Profitability
Gross Margin
75.00%
Operating Margin
51.98%
Profit Margin
49.51%
Returns and Earnings
Return on Assets (TTM)
16.11%
Return on Equity (TTM)
17.58%
EBITDA
INR667.1M
Net Income (TTM)
INR491.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR115.66
Quarterly Revenue Growth (YoY)
14.40%
Quarterly Earnings Growth (YoY)
13.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| 3B Blackbio 3BBLACKBIO | 12.33B Small-cap | -11.51% | -1.70% | -25.19% | -20.50% | -27.08% | 2.74% | 80.63% | 80.63% |
| Biocon BIOCON | 479.78B Large-cap | -1.19% | -8.68% | 8.30% | 12.06% | -2.40% | 0.24% | 21.77% | -14.49% |
| OneSource Specialty ONESOURCE | 212.97B Large-cap | 2.92% | -3.60% | 6.75% | 39.66% | 10.15% | 10.15% | 10.15% | 10.15% |
| Dishman Carbogen DCAL | 42.04B Small-cap | 6.31% | 11.88% | 2.89% | 29.89% | -1.95% | 37.76% | 132.64% | 50.89% |
| Zota Health Care ZOTA | 32.82B Small-cap | -9.12% | 2.79% | 23.33% | 45.25% | 54.94% | 87.10% | 365.15% | 725.42% |
| Panacea Biotec PANACEABIO | 25.00B Small-cap | -1.20% | -3.47% | -25.64% | 25.69% | -8.21% | 79.88% | 188.45% | 155.14% |
Ownership & Short Interest
Insider Ownership
64.95%
Institutional Ownership
1.74%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
12K
Average 90-Day Volume
8K
3B Blackbio Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in 3B Blackbio would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is 3BBLACKBIO's 52-week high and low?
- In the last 52 weeks, 3B Blackbio reached a high of ₹2,350.00 (on December 11, 2024) and a low of ₹1,253.80 (on October 7, 2024).
- What is the market cap and P/E ratio for 3BBLACKBIO?
- Curious about 3B Blackbio's size and valuation? Its market capitalization stands at 12.33B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.06, and the forward P/E (looking ahead) is N/A.
- Does 3BBLACKBIO pay dividends? If so, what's the yield?
- As for dividends, 3B Blackbio isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are 3B Blackbio's main competitors or similar companies to consider before investing?
When looking at 3B Blackbio, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON479.78B Healthcare Biotechnology 0.24% 21.77% OneSource Specialty
ONESOURCE212.97B Healthcare Biotechnology 10.15% 10.15% Dishman Carbogen
DCAL42.04B Healthcare Biotechnology 37.76% 132.64% Zota Health Care
ZOTA32.82B Healthcare Biotechnology 87.10% 365.15% Panacea Biotec
PANACEABIO25.00B Healthcare Biotechnology 79.88% 188.45% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for 3B Blackbio Diagnostics Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of 3B Blackbio's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.58%, the Debt to Equity ratio from the most recent quarter is 0.11, and its Gross Profit Margin stands at 75.00%.
- What is the recent revenue and earnings growth for 3BBLACKBIO?
- Looking at 3B Blackbio's growth, its revenue over the trailing twelve months (TTM) was INR993M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.40%, and quarterly earnings saw a YoY growth of 13.10%.
- How much of 3BBLACKBIO stock is held by insiders and institutions?
- Wondering who owns 3B Blackbio stock? Company insiders (like executives and directors) hold about 64.95% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.